Literature DB >> 11377973

The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.

M Goedert1.   

Abstract

Intracellular filamentous inclusions made of either the microtubule-associated protein tau or the protein alpha-synuclein define the majority of cases of neurodegenerative disease. Mutations in the tau gene in familial forms of frontotemporal dementia and in the alpha-synuclein gene in familial cases of Parkinson's disease have provided causal links between the dysfunction of these proteins and neurodegeneration. Over the past year, several novel tau gene mutations have been identified and more has been learned about possible mechanisms by which tau gene mutations lead to frontotemporal dementia. Experimental animal models have provided a link between tau filament formation and nerve cell degeneration. Along similar lines, animal models have been produced that result in the formation of alpha-synuclein filaments and the degeneration of dopaminergic nerve cells. Building on previous work, synthetic alpha-synuclein filaments have been shown to exhibit the characteristics of amyloid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377973     DOI: 10.1016/s0959-437x(00)00200-8

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  23 in total

1.  Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse.

Authors:  Isin Unal-Cevik; Yasemin Gursoy-Ozdemir; Muge Yemisci; Sevda Lule; Gunfer Gurer; Alp Can; Veronica Müller; Philip J Kahle; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

Review 2.  The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

Authors:  Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007-12-04       Impact factor: 3.444

3.  Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson's disease cases.

Authors:  Heiko Braak; Dietmar R Thal; Kelly Del Tredici
Journal:  J Neural Transm (Vienna)       Date:  2010-11-05       Impact factor: 3.575

4.  Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.

Authors:  Diana Poppek; Susi Keck; Gennady Ermak; Tobias Jung; Alexandra Stolzing; Oliver Ullrich; Kelvin J A Davies; Tilman Grune
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

Review 5.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

6.  Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edith Schreiner; Robert Wronski
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila.

Authors:  Michael J Palladino; Tricia J Hadley; Barry Ganetzky
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

8.  Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.

Authors:  Lea Tenenholz Grinberg; Xuehua Wang; Chao Wang; Peter Dongmin Sohn; Panos Theofilas; Manu Sidhu; John Benjamin Arevalo; Helmut Heinsen; Eric J Huang; Howard Rosen; Bruce L Miller; Li Gan; William W Seeley
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

9.  pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.

Authors:  Ashutosh Tripathi; Zalak S Parikh; Parvez Vora; Emma E Frost; Prakash P Pillai
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

10.  17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.

Authors:  Michael Riedel; Olaf Goldbaum; Lisa Schwarz; Sebastian Schmitt; Christiane Richter-Landsberg
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.